October 29, 2001
AmeriPath Announces Over-Allotment Option in Public Offering
FOR IMMEDIATE RELEASE

Contact: Gregory A. Marsh Michelle D. Getty Vice President & CFO Investor Relations AmeriPath, Inc. AmeriPath, Inc. 561-712-6211 561-712-6260 E-mail: gmarsh@ameripath.com E-mail: invrel@ameripath.com

AMERIPATH ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION IN PUBLIC OFFERING

Riviera Beach, FL, October 29, 2001 - AmeriPath, Inc. (Nasdaq:PATH), one of the nation's leading providers of anatomic pathology services, today announced that the underwriters of its recent public offering of common stock have exercised in full their over-allotment option to purchase an additional 618,750 shares. All of the over-allotment shares are being sold by the Company. After giving effect to the sale of the over-allotment shares, a total of 4,743,750 of common stock will have been sold by the Company at a price of $26.00 per share. Salomon Smith Barney acted as book-running manager, and Credit Suisse First Boston, U.S. Bancorp Piper Jaffray, and Wachovia Securities were co-managers of the underwriting group for the offering.

Net proceeds from the offering will be used to repay indebtedness under the Company's credit facility.

A final prospectus relating to the offering of the shares may be obtained from Salomon Smith Barney, Brooklyn Army Terminal, 140 58th Street, 8th floor, Brooklyn, NY 11220, (718)765-6732.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.